BRCA2 and BRCA1 PTVs were associated with an increased burden of small somatic deletions, tandem duplications, and templated insertions in breast and ovarian cancers as well as other tumors like adenocarcinomas of the prostate and pancreas. Here, BRCA1 is linked to ovarian carcinoma.